MCL coexpression mm9:503
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:114622071..114622085,- | p1@Tph2 |
Mm9::chr13:73674229..73674258,+ | p1@Slc6a3 |
Mm9::chr19:40804786..40804795,- | p@chr19:40804786..40804795 - |
Mm9::chr1:183734229..183734244,+ | p@chr1:183734229..183734244 + |
Mm9::chr2:144300607..144300618,- | p@chr2:144300607..144300618 - |
Mm9::chr7:126874249..126874254,+ | p@chr7:126874249..126874254 + |
Mm9::chr7:134085595..134085606,+ | p6@Kctd13 |
Mm9::chr7:142460262..142460264,+ | p1@Nps |
Mm9::chr8:74243126..74243137,- | p@chr8:74243126..74243137 - |
Mm9::chr9:120088834..120088845,+ | p@chr9:120088834..120088845 + |
Mm9::chr9:120088982..120088991,+ | p@chr9:120088982..120088991 + |
Mm9::chr9:120089021..120089032,+ | p@chr9:120089021..120089032 + |
Mm9::chr9:44961019..44961022,+ | p@chr9:44961019..44961022 + |
Mm9::chr9:46721556..46721563,+ | p5@2900052N01Rik |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0042136 | neurotransmitter biosynthetic process | 0.000245733661229158 |
GO:0042401 | biogenic amine biosynthetic process | 0.000396736791075821 |
GO:0042398 | amino acid derivative biosynthetic process | 0.000396736791075821 |
GO:0042133 | neurotransmitter metabolic process | 0.000524086817436587 |
GO:0009309 | amine biosynthetic process | 0.00107626548464798 |
GO:0006576 | biogenic amine metabolic process | 0.00127972276824526 |
GO:0044271 | nitrogen compound biosynthetic process | 0.00127972276824526 |
GO:0006575 | amino acid derivative metabolic process | 0.00133631109211284 |
GO:0001505 | regulation of neurotransmitter levels | 0.00133631109211284 |
GO:0006725 | aromatic compound metabolic process | 0.00198630802753521 |
GO:0005329 | dopamine transmembrane transporter activity | 0.00261476320206392 |
GO:0007268 | synaptic transmission | 0.00383477591649904 |
GO:0004510 | tryptophan 5-monooxygenase activity | 0.00383477591649904 |
GO:0006587 | serotonin biosynthetic process from tryptophan | 0.00383477591649904 |
GO:0042427 | serotonin biosynthetic process | 0.00383477591649904 |
GO:0019226 | transmission of nerve impulse | 0.00454093319721234 |
GO:0042435 | indole derivative biosynthetic process | 0.00454093319721234 |
GO:0046219 | indolalkylamine biosynthetic process | 0.00454093319721234 |
GO:0015844 | monoamine transport | 0.00454093319721234 |
GO:0042424 | catecholamine catabolic process | 0.0050013335388711 |
GO:0008504 | monoamine transmembrane transporter activity | 0.0050013335388711 |
GO:0042420 | dopamine catabolic process | 0.0050013335388711 |
GO:0042416 | dopamine biosynthetic process | 0.0050013335388711 |
GO:0006519 | amino acid and derivative metabolic process | 0.00514984371433935 |
GO:0060134 | prepulse inhibition | 0.00522809391882235 |
GO:0042428 | serotonin metabolic process | 0.00522809391882235 |
GO:0015872 | dopamine transport | 0.00522809391882235 |
GO:0007267 | cell-cell signaling | 0.00522809391882235 |
GO:0009308 | amine metabolic process | 0.00522809391882235 |
GO:0042069 | regulation of catecholamine metabolic process | 0.00522809391882235 |
GO:0042053 | regulation of dopamine metabolic process | 0.00522809391882235 |
GO:0021984 | adenohypophysis development | 0.00522809391882235 |
GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen | 0.00522809391882235 |
GO:0006807 | nitrogen compound metabolic process | 0.00559084963740589 |
GO:0048585 | negative regulation of response to stimulus | 0.00559084963740589 |
GO:0032102 | negative regulation of response to external stimulus | 0.00559084963740589 |
GO:0016597 | amino acid binding | 0.00605291905027066 |
GO:0006568 | tryptophan metabolic process | 0.00605291905027066 |
GO:0032101 | regulation of response to external stimulus | 0.00663456693294463 |
GO:0042135 | neurotransmitter catabolic process | 0.0070117596717797 |
GO:0042423 | catecholamine biosynthetic process | 0.0070117596717797 |
GO:0006586 | indolalkylamine metabolic process | 0.00714522281916839 |
GO:0042434 | indole derivative metabolic process | 0.00714522281916839 |
GO:0042430 | indole and derivative metabolic process | 0.00714522281916839 |
GO:0008324 | cation transmembrane transporter activity | 0.00714522281916839 |
GO:0001964 | startle response | 0.00749871236088418 |
GO:0042402 | biogenic amine catabolic process | 0.00838305815551868 |
GO:0015238 | drug transporter activity | 0.00838305815551868 |
GO:0043176 | amine binding | 0.00862210157262331 |
GO:0007595 | lactation | 0.00862210157262331 |
GO:0042219 | amino acid derivative catabolic process | 0.00901608267680635 |
GO:0021983 | pituitary gland development | 0.00975926500261984 |
GO:0005328 | neurotransmitter:sodium symporter activity | 0.00975926500261984 |
GO:0021536 | diencephalon development | 0.0102615942627065 |
GO:0042417 | dopamine metabolic process | 0.0102615942627065 |
GO:0005326 | neurotransmitter transporter activity | 0.0102615942627065 |
GO:0015075 | ion transmembrane transporter activity | 0.0103706484546386 |
GO:0040018 | positive regulation of multicellular organism growth | 0.0108973261830475 |
GO:0009072 | aromatic amino acid family metabolic process | 0.012171436752033 |
GO:0045927 | positive regulation of growth | 0.0124466403825088 |
GO:0022891 | substrate-specific transmembrane transporter activity | 0.0128093772529445 |
GO:0018958 | phenol metabolic process | 0.0132195317952135 |
GO:0006584 | catecholamine metabolic process | 0.0132195317952135 |
GO:0005275 | amine transmembrane transporter activity | 0.0152524120061469 |
GO:0005887 | integral to plasma membrane | 0.0153533224358322 |
GO:0031226 | intrinsic to plasma membrane | 0.0153533224358322 |
GO:0042446 | hormone biosynthetic process | 0.0153533224358322 |
GO:0022857 | transmembrane transporter activity | 0.0153533224358322 |
GO:0044249 | cellular biosynthetic process | 0.0156394999726839 |
GO:0015370 | solute:sodium symporter activity | 0.0164005598667272 |
GO:0022892 | substrate-specific transporter activity | 0.0175356412586621 |
GO:0048583 | regulation of response to stimulus | 0.0175356412586621 |
GO:0050905 | neuromuscular process | 0.0183605712295719 |
GO:0006836 | neurotransmitter transport | 0.0183605712295719 |
GO:0035270 | endocrine system development | 0.0183605712295719 |
GO:0015294 | solute:cation symporter activity | 0.019369730084487 |
GO:0040014 | regulation of multicellular organism growth | 0.019369730084487 |
GO:0015837 | amine transport | 0.0194880506720306 |
GO:0008076 | voltage-gated potassium channel complex | 0.0196033360204182 |
GO:0044270 | nitrogen compound catabolic process | 0.0198252506733136 |
GO:0009310 | amine catabolic process | 0.0198252506733136 |
GO:0035264 | multicellular organism growth | 0.0213261550776926 |
GO:0046483 | heterocycle metabolic process | 0.022789946925116 |
GO:0009058 | biosynthetic process | 0.0232665618871751 |
GO:0048609 | reproductive process in a multicellular organism | 0.0236547437368107 |
GO:0032504 | multicellular organism reproduction | 0.0236547437368107 |
GO:0048732 | gland development | 0.0243668471794751 |
GO:0042445 | hormone metabolic process | 0.0263586050610545 |
GO:0005249 | voltage-gated potassium channel activity | 0.0267030274387872 |
GO:0030900 | forebrain development | 0.0317851837882304 |
GO:0044459 | plasma membrane part | 0.0349696633938186 |
GO:0022843 | voltage-gated cation channel activity | 0.0360376064106183 |
GO:0005267 | potassium channel activity | 0.0374817260078045 |
GO:0004497 | monooxygenase activity | 0.0375887222634755 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 0.0375887222634755 |
GO:0015293 | symporter activity | 0.0395604078330576 |
GO:0040008 | regulation of growth | 0.0431677574714076 |
GO:0050877 | neurological system process | 0.0431677574714076 |
GO:0006813 | potassium ion transport | 0.0440818140889795 |
GO:0022832 | voltage-gated channel activity | 0.0471263956989121 |
GO:0005244 | voltage-gated ion channel activity | 0.0471263956989121 |
GO:0042802 | identical protein binding | 0.0478395716640774 |
GO:0003008 | system process | 0.0478395716640774 |
GO:0015291 | secondary active transmembrane transporter activity | 0.0482096120638034 |
GO:0007420 | brain development | 0.0495169241756483 |
GO:0005886 | plasma membrane | 0.0495169241756483 |
Relative expression of the co-expression cluster over median <br>Analyst:
"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
Ontology term | p-value | n |
---|
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |